PAPER Koc M, Karaarslan O, Abali G, Batur MK

Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.

Tex Heart Inst J. 2010;37(1):42-8. PubMed.

PAPER Ahmed MB

Alzheimer's disease: recent advances in etiology, diagnosis, and management.

Tex Med. 2001 Dec;97(12):50-8. PubMed.

PAPER Hogg E, Wu T, Bresee C, Wertheimer J, Malatt C, Tan E, Pomeroy H, Nuno M, Wyse R, Tagliati M

A Phase II, Randomized, Double-Blinded, Placebo-Controlled Trial of Liraglutide in Parkinson's Disease

Preprints with The Lancet, 12 September 2022 . The Lancet Preprint

PAPER Perry G

When hypotheses dominate

The Scientist. 2004 Dec 8;18(23):6. .

PAPER Aranda-Abreu GE, Hernández ME, Soto A, Manzo J

Possible Cis-acting signal that could be involved in the localization of different mRNAs in neuronal axons.

Theor Biol Med Model. 2005;2:33. PubMed.

PAPER Reed MC, Thomas RL, Pavisic J, James SJ, Ulrich CM, Nijhout HF

A mathematical model of glutathione metabolism.

Theor Biol Med Model. 2008;5:8. PubMed.

PAPER Ul-Haq Z, Khan W, Kalsoom S, Ansari FL

In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of beta-amyloid plaques associated with Alzheimer's disease.

Theor Biol Med Model. 2010;7:22. PubMed.

PAPER Han K, Kim SH, Choi M

Computational modeling of the effects of autophagy on amyloid-β peptide levels.

Theor Biol Med Model. 2020 Feb 26;17(1):2. PubMed.

PAPER Sundar S, Battistoni C, McNulty R, Morales F, Gorky J, Foley H, Dhurjati P

An agent-based model to investigate microbial initiation of Alzheimer's via the olfactory system.

Theor Biol Med Model. 2020 Apr 15;17(1):5. PubMed.

PAPER Philippe P, Mansi O

Nonlinearity in the epidemiology of complex health and disease processes.

Theor Med Bioeth. 1998 Dec;19(6):591-607. PubMed.

PAPER De Vreese L, Weber E, Van Bouwel J

Explanatory pluralism in the medical sciences: theory and practice.

Theor Med Bioeth. 2010 Oct;31(5):371-90. PubMed.

PAPER Daly T, Mastroleo I, Gorski D, Epelbaum S

The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols.

Theor Med Bioeth. 2020 Dec;41(5-6):223-237. Epub 2021 Jan 18 PubMed.

PAPER Brinks R, Landwehr S

Age- and time-dependent model of the prevalence of non-communicable diseases and application to dementia in Germany.

Theor Popul Biol. 2014 Mar;92:62-8. Epub 2013 Dec 10 PubMed.

PAPER Bordonaro M

Hypothesis: functional age and onset of autosomal dominant genetic prion disease.

Theory Biosci. 2023 Jun;142(2):143-150. Epub 2023 Apr 5 PubMed.

PAPER Stone JG, Casadesus G, Gustaw-Rothenberg K, Siedlak SL, Wang X, Zhu X, Perry G, Castellani RJ, Smith MA

Frontiers in Alzheimer's disease therapeutics.

Ther Adv Chronic Dis. 2011 Jan 1;2(1):9-23. PubMed.